Helena Reijonen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Regulatory T Cells

Glycemic Control

Cardiovascular Disease

Top Venues

Science advances

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Nagesha Guthalu Kondegowda, Joanna Filipowska, Jeong-Su Do, Nancy Leon-Rivera, Rosemary Li, Rollie Hampton, Selassie Ogyaadu, Camilla Levister, Josef M Penninger, Helena Reijonen, Carol J Levy, Rupangi C Vasavada
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes. Science advances 9 (44) (2023)
Xiaomin Wen, Junbao Yang, Eddie A James, I-Ting Chow, Helena Reijonen, William Wai-Hung Kwok
Increased islet antigen-specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes-protective haplotype. Science immunology 5 (44) (2020)